Spectrum Wealth Advisory Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Spectrum Wealth Advisory Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-86	Closed	-$2.7K	–	172
2026 Q2	$2.7K	Buy	+86	New	+$2.54K	﹤0.01%	299

Other funds holding CPRX

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Spectrum Wealth Advisory Group's CPRX Position: Q3 2026 in Review

Spectrum Wealth Advisory Group sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 86 shares — an estimated $2.7K sold.

Spectrum Wealth Advisory Group first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $2.7K in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

Spectrum Wealth Advisory Group reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Spectrum Wealth Advisory Group sold 86 Catalyst Pharmaceutical shares in Q3 2026, an estimated $2.7K.
Spectrum Wealth Advisory Group first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
Spectrum Wealth Advisory Group's Catalyst Pharmaceutical position peaked at $2.7K in Q2 2026.
2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Spectrum Wealth Advisory Group's 13F filing for Q3 2026, filed 29 Oct 2026.